Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-037753
Filing Date
2004-07-29
Accepted
2004-07-29 18:46:34
Documents
1
Period of Report
2004-07-27

Document Format Files

Seq Description Document Type Size
1 rrd49243.html 4  
1 rrd49243.xml 4 7439
  Complete submission text file 0001181431-04-037753.txt   9277
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Issuer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 PARK AVENUE NEW YORK NY 10022
Business Address 500 PARK AVENUE NEW YORK NY 10022 2129356655
TISCH DANIEL R (Reporting) CIK: 0001111794 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 04940217